Akron Childrens Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• ANCA-associated vasculitis1 trial
• Cystic fibrosis1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Amgen1 trial
• Anagram Therapeutics, Inc.1 trial

Running trials

• Active, not recruiting

  Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

  NCT06321601· Phase 3· Amgen· Source

Closed trials

• Completed

  Phase 1 Study to Assess Safety and Efficacy of ANG003

  NCT06052293· Phase 1· Anagram Therapeutics, Inc.· Source